← Eichor
Study identifier: NCT04390035 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

BFRT in Adolescents After ACL Reconstruction

Condition: Anterior Cruciate Ligament Rupture  ·  Sponsor: Children's Healthcare of Atlanta

PhaseNA
Planned participants120
Who can joinAll sexes, 12 Years to 18 Years
Healthy volunteersYes

About this study

This is an interventional study that will examine effects of blood flow restriction training (BFRT) in adolescents aged 12-18 after anterior cruciate ligament reconstruction surgery (ACLR). The study aims to identify the effect of BFRT on quadriceps muscle strength and the patient's quality of life, and the overall tolerability of BFRT will be examined. Eight physical therapists at four sports medicine physical therapy (PT) sites will oversee all post-operative PT sessions. Subjects allocated to the BFR group will undergo BFRT, while control group will undergo standard-of-care ACLR rehabilitation, 2 days per week for 16 weeks. Measurements of strength, quality of life, and overall function will be completed at regular intervals.

This description comes directly from the study's public registry record.

Talk to the study team

Jeanne Graf, PT, DPT, ATC  ·  404-785-8421  ·  jeannie.graf@chao.org

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Healthcare of Atlanta Physical TherapyAtlanta, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04390035